BANGKOK — Three Covid-19 vaccines are undergoing human trials while more than 20 are in the research phase, the National Research Council of Thailand and National Vaccine Institute said.
The Thai government’s Covid-19 Information Centre announced on Sunday that combined data from the two institutes revealed more than 20 vaccines are being researched and developed in Thailand, while three have started human trials.
The three in human trials stage are:
– ChulaCov19, an MRNA vaccine developed by Chulalongkorn University. It is in the first phase of human trials among 72 candidates. Two doses of the vaccine were given at an interval o…
Keep on reading: COVID-19 vaccines developed by Thai researchers undergoing human trials